ICICI Pru MNC Fund
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space.
Growthvine rating: 3/5 — ranked #48 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹28.01 (as of 2026-10-21) |
|---|
| AUM | ₹1,703 Cr |
|---|
| Expense ratio | 1.79% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Roshan Chutkey |
|---|
| Exit load | 1% for redemption within 1 month |
|---|
Performance & risk
| 5-year annualised return | 9.60% |
|---|
| Sharpe ratio | 0.25 |
|---|
| Standard deviation | 14.00% |
|---|
| Max drawdown | −30.90% |
|---|
| Alpha | -0.22 |
|---|
| Beta | 0.84 |
|---|
Over 5 years, captured 43.4% of NIFTY CPSE's upside and 49.5% of its downside.
Market cap allocation
| Large cap | 44.7% |
|---|
| Mid cap | 23.1% |
|---|
| Small cap | 32.1% |
|---|
Concentration
| Top 5 holdings | 27.6% |
|---|
| Top 10 holdings | 46.3% |
|---|
| Total holdings | 50 |
|---|
Top holdings
- Hindustan Unilever Ltd. — 7.1%
- Maruti Suzuki India Ltd. — 6.2%
- Sona BLW Precision Forgings Limited — 4.9%
- Britannia Industries Ltd. — 4.8%
- Nestle India Ltd. — 4.6%
- Sun Pharmaceutical Industries Ltd. — 4.1%
- Dr. Reddys Laboratories Ltd. — 4.0%
- Vedanta Aluminium Metal Limited — 3.8%
- HYUNDAI MOTOR INDIA LIMITED — 3.8%
- TREPS — 3.3%
Top sectors
- Automobile — 23.3%
- Pharma & Biotech — 18.6%
- Food Beverage & Tobacco — 14.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −5.0% | Q2 | #74 of 167 |
| 2025 | 5.4% | Q2 | #55 of 132 |
| 2024 | 16.4% | Q3 | #64 of 86 |
| 2023 | 26.5% | Q3 | #45 of 66 |
| 2022 | −0.4% | Q3 | #34 of 55 |